Braskem S.A. Files 6-K Report

Ticker: BAK · Form: 6-K · Filed: Sep 29, 2025 · CIK: 1071438

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Braskem S.A. filed its 6-K report for Sept 2025, confirming its status as a foreign private issuer.

AI Summary

Braskem S.A. filed a Form 6-K on September 29, 2025, for the reporting period ending September 30, 2025. The filing indicates Braskem S.A. is a foreign private issuer and is submitting its report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The company's principal executive offices are located in Camacari, Bahia, Brazil.

Why It Matters

This filing provides routine updates for Braskem S.A., a significant player in the petrochemical industry, informing investors about its ongoing compliance and reporting status.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information required by Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 for the month of September 2025.

What is Braskem S.A.'s filing status regarding annual reports?

Braskem S.A. indicates it files annual reports under cover of Form 20-F.

Where are Braskem S.A.'s principal executive offices located?

Braskem S.A.'s principal executive offices are located at Rua Eteno, 1561, Polo Petroquimico de Camacari, Camacari, Bahia - CEP 42810-000, Brazil.

What was Braskem S.A.'s former company name?

Braskem S.A.'s former company name was COPENE PETROQUIMICA DO NORDESTE SA.

What is the filing date and reporting period for this 6-K?

This 6-K was filed as of September 29, 2025, and is for the reporting period ending September 30, 2025.

Filing Stats: 4,677 words · 19 min read · ~16 pages · Grade level 16 · Accepted 2025-09-26 18:19:01

Filing Documents

financial statements of the Company;

financial statements of the Company; xvii. Evaluate, prior to BoD’s deliberation, any matter from the Compliance System that may be submitted to the BoD by those responsible for Compliance, Risks, Internal Controls, and Internal Audit; xviii. Conduct, monitor and review the results of investigations regarding matters within the scope of its duties or when it involves the R-Compliance or any member from its staff, in addition to analyzing the results of investigations involving members of the BoD, the Braskem Business Leader (“ Braskem BL ”) or anyone directly under their command; xix. Propose to the BoD supplementary Policies required for the CCAE’s operations, as well as the update of the Company’s Policies regarding compliance, and promoting their implementation with a focus on education, awareness and prevention; Page 5 of 18 xx. Pursue the continuous improvement of Braskem’s Compliance System, promoting interaction with renowned domestic and international entities aimed at the best compliance practices; xxi. Interact with members, independent auditors, legal advisors and other external advisors, as required, to improve the Company’s compliance practices; xxii. Provide the operating experience of the CCAE to the members of the Company and its controlled companies, seeking to improve compliance in their respective businesses; xxiii. Evaluate, prior to BoD’s deliberation, the appropriateness of transactions of Transactions with Related Parties of the Company, observing the provisions in item 2.2 of these Rules as well as to carry out the monitoring, including the respective evidences, jointly with the Management and the internal audit area, considering the report to be submitted quarterly, by the Corporate Governance Area, consolidating the relevant information on re

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 26, 2025 BRASKEM S.A. By: /s/ Felipe Montoro Jens Name: Felipe Montoro Jens Title: Chief Financial Officer DISCLAIMER ON FORWARD-LOOKING STATEMENTS This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, in

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing